共 174 条
[1]
Atkins M(2005)Carbonic anhydrase IX expression predicts outcome of interleukin-2 therapy for renal cancer Clin Cancer Res 11 3714-21
[2]
Regan M(2001)Cytokine therapy for metastatic renal cell carcinoma Semin Urol Oncol 19 148-54
[3]
McDermott D(2007)Sorafenib in advanced clear-cell renal-cell carcinoma N Engl J Med 356 125-134
[4]
Mier J(2001)Chemical synthesis and biological activity of bromohydrin pyrophosphate, a potent stimulator of human γδ T cells J Biol Chem 276 18337-18344
[5]
Stanbridge E(2001)Targeting of tumor cells for human γδ T cells by nonpeptide antigens J Immunol 167 5092-5098
[6]
Youmans A(2001)Gamma/delta T cells provide innate immunity against renal cell carcinoma Cancer Immunol Immunother 50 115-124
[7]
Febbo P(2006)Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma: a pilot study Cancer Immunol Immunother 56 469-476
[8]
Upton M(1999)Interferon-α and survival in metastatic renal carcinoma: early results of a randomised controlled trial Lancet 353 14-17
[9]
Lechpammer M(1999)Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma J Clin Oncol 17 2530-2540
[10]
Signoretti S(2007)Sunitinib versus interferon alfa in metastatic renal-cell carcinoma N Engl J Med 356 115-124